In addition, correlation analyses showed that the density of GPC3-CAR T cells in mouse peripheral blood significantly (P < 0.05) negatively correlated with the tumor burdens in both treatment groups of wild-type and PD-1-deficient GPC3-CAR T cells. This evidence concerns the gene GPC3 and neoplasm.